Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte (M2iSH), Université Clermont Auvergne/Inserm, Clermont-Ferrand, France.
3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastro Entérologie, Université Clermont Auvergne, Inserm, Clermont-Ferrand, France.
Gut Microbes. 2024 Jan-Dec;16(1):2412667. doi: 10.1080/19490976.2024.2412667. Epub 2024 Oct 14.
We investigated the role of ChiA and its associated polymorphisms in the interaction between Crohn's disease (CD)-associated adherent-invasive (AIEC) and intestinal mucosa. We observed a higher abundance of among the metagenome of CD patients compared to healthy subjects. In dextran sulfate sodium-induced colitis mice model, AIEC-LF82∆ colonization was reduced in ileal, colonic and fecal samples compared to wild-type LF82. The binding of ChiA to recombinant human CHI3L1 or mucus was higher with the pathogenic polymorphism. The strength of ChiA-mucin interaction was 300-fold stronger than ChiA-rhCHI3L1. ChiA was able to degrade mucin to promote its growth and enabled LF82 to get closer to epithelial cells. The pathogenic polymorphism of ChiA had a stronger impact on mucus degradation than on the binding capability of AIEC to adhere to the intestinal epithelium. We observed that ChiA could favor an efficient bacterial invasion of intestinal crypts, and that ChiA, especially its pathogenic polymorphism, gives LF82 an advantage to uptake within Peyer's patches, macrophages and mesenteric lymph nodes. All together, these data support the role of ChiA in the virulence of AIEC and show that it could be a promising target to reduce AIEC colonization in patients with CD.
我们研究了 ChiA 及其相关多态性在克罗恩病(CD)相关黏附侵袭性(AIEC)与肠道黏膜相互作用中的作用。我们观察到 CD 患者的宏基因组中 ChiA 的丰度高于健康受试者。在葡聚糖硫酸钠诱导的结肠炎小鼠模型中,与野生型 LF82 相比,AIEC-LF82∆在回肠、结肠和粪便样本中的定植减少。ChiA 与重组人 CHI3L1 或粘蛋白的结合能力在致病多态性下更高。ChiA-粘蛋白相互作用的强度比 ChiA-rhCHI3L1 强 300 倍。ChiA 能够降解粘蛋白以促进其生长,并使 LF82 更接近上皮细胞。ChiA 的致病多态性对粘蛋白降解的影响强于 AIEC 与肠道上皮黏附的结合能力。我们观察到 ChiA 可以促进细菌有效地入侵肠道隐窝,并且 ChiA,尤其是其致病多态性,使 LF82 能够更有效地摄取派尔集合淋巴结、巨噬细胞和肠系膜淋巴结。所有这些数据都支持 ChiA 在 AIEC 毒力中的作用,并表明它可能是减少 CD 患者 AIEC 定植的有前途的靶点。